Qingqin Gao
Beijing, 100049, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting RAS-mutant cancer cells using a synthetic RAS-activated cancer killing system.
Journal: Trends in biotechnology
Published: July 02, 2025
Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR-Cas12f1 System Delivered with All-in-One Adeno-Associated Virus.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 25, 2023
Targeting non-muscle myosin II inhibits proliferative vitreoretinopathy through regulating epithelial-mesenchymal transition.
Journal: Biochemical and biophysical research communications
Published: October 09, 2023
Programmable synthetic receptors: the next-generation of cell and gene therapies.
Journal: Signal transduction and targeted therapy
Published: May 30, 2023
Artificial sgRNAs engineered for genome editing with new Cas12b orthologs.
Journal: Cell discovery
Published: January 21, 2019
Repurposing CRISPR-Cas12b for mammalian genome engineering.
Journal: Cell discovery
Published: September 17, 2018
Enhanced mammalian genome editing by new Cas12a orthologs with optimized crRNA scaffolds.
Journal: Genome biology
Published: July 02, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026